Testosterone Cypionate — reference
Long-acting injectable testosterone ester for testosterone replacement in men with diagnosed hypogonadism.
Regulatory status
FDA-Approved (labeled use). FDA-approved for male hypogonadism. A Schedule III controlled substance in the US; possession without a prescription is a federal offense.
Reported cautions
Pharmacokinetics
Published figures give an elimination half-life of ~8 days. Ester-controlled release from IM/subQ depot, not native testosterone's own ~10–100 min half-life.
This figure is tagged FDA label in our evidence system. This figure appears in an approved product's prescribing information, which is the strongest tier in our system — a regulator-reviewed number for a specific approved product. You can see the shape this implies between doses in the Half-Life Visualizer, and compare it against every other compound in the Half-Life Data Table. Our sourcing page explains what each tier means.
Remember that an estimated curve is a model built from a population figure, not a measurement of your blood. Individual clearance varies, and for depot injections the figure describes release from the injection site rather than the compound clearing. Half-life explained →
What Peptide Plug does and does not publish
This page carries regulatory status, general context and published pharmacokinetics. It carries no dose, frequency or cycle information — that is a deliberate editorial line, because dosing is a clinical decision rather than reference data. We also do not sell, supply, source or link to vendors for any compound.
Frequently asked
Is Testosterone Cypionate FDA-approved?
What is the half-life of Testosterone Cypionate?
How reliable is that half-life figure?
What cautions are associated with Testosterone Cypionate?
Does Peptide Plug publish dosing for Testosterone Cypionate?
Does Peptide Plug sell Testosterone Cypionate?
Related tools
Free, no account required.
The public research page intentionally does not publish dosing. Pro subscribers can open the separate Protocol Library for structured indication, frequency, duration, notes, and review-first Cycle Builder import when a matching reference is available.
View Protocol Reference